| Hy-vee Pharmacy (1356) | |
| 16150 Pilot Knob Rd, Lakeville, Minnesota 55044 | |
| (952) 423-9342 |
| Name | Hy-vee Pharmacy (1356) |
|---|---|
| Organization Name | Hy Vee Inc |
| Location | 16150 Pilot Knob Rd, Lakeville, Minnesota 55044 |
| Type | Community/Retail Pharmacy |
| Phone | (952) 423-9342 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Applying imaging techniques to food structure is helping scientists devise ways of improving the quality of processed food. Food's microstructure can explain many of its characteristics—be it cake's sponginess, bread's crispness, cracker's crunchiness or fruits' inner gas and water transport system and even colour. Understanding such microstructure and how it changes during food processing is essential to produce high-quality food.
Profound suppression of the hepatitis C virus reduces long-term hepatic inflammation and fibrosis even in patients who do not achieve a sustained virologic response, research demonstrates.
Oncolytics Biotech Inc. announced today that it has completed Phase I patient enrollment in its Phase I/II clinical trial to investigate the use of REOLYSIN(R) for patients with recurrent malignant gliomas (REO 007). The principal investigator is Dr. James Markert, Division Director of Neurosurgery, and Professor, Neurosurgery and Physiology, the University of Alabama at Birmingham.
The U.S. Food and Drug Administration today is requiring safety labeling changes for a class of antibiotics called fluoroquinolones to strengthen the warnings about the risks of mental health side effects and serious blood sugar disturbances, and make these warnings more consistent across the labeling for all fluoroquinolones taken by mouth or given by injection.
› Verified 6 days ago
| NPI Number | 1851746986 |
| Organization Name | HY-VEE INC |
| Doing Business As | HY-VEE PHARMACY (1356) |
| Type | Community/Retail Pharmacy |
| Address | 16150 Pilot Knob Rd, Lakeville, MN 55044 |
| Phone Number | 952-423-9342 |
News Archive
Applying imaging techniques to food structure is helping scientists devise ways of improving the quality of processed food. Food's microstructure can explain many of its characteristics—be it cake's sponginess, bread's crispness, cracker's crunchiness or fruits' inner gas and water transport system and even colour. Understanding such microstructure and how it changes during food processing is essential to produce high-quality food.
Profound suppression of the hepatitis C virus reduces long-term hepatic inflammation and fibrosis even in patients who do not achieve a sustained virologic response, research demonstrates.
Oncolytics Biotech Inc. announced today that it has completed Phase I patient enrollment in its Phase I/II clinical trial to investigate the use of REOLYSIN(R) for patients with recurrent malignant gliomas (REO 007). The principal investigator is Dr. James Markert, Division Director of Neurosurgery, and Professor, Neurosurgery and Physiology, the University of Alabama at Birmingham.
The U.S. Food and Drug Administration today is requiring safety labeling changes for a class of antibiotics called fluoroquinolones to strengthen the warnings about the risks of mental health side effects and serious blood sugar disturbances, and make these warnings more consistent across the labeling for all fluoroquinolones taken by mouth or given by injection.
› Verified 6 days ago
News Archive
Applying imaging techniques to food structure is helping scientists devise ways of improving the quality of processed food. Food's microstructure can explain many of its characteristics—be it cake's sponginess, bread's crispness, cracker's crunchiness or fruits' inner gas and water transport system and even colour. Understanding such microstructure and how it changes during food processing is essential to produce high-quality food.
Profound suppression of the hepatitis C virus reduces long-term hepatic inflammation and fibrosis even in patients who do not achieve a sustained virologic response, research demonstrates.
Oncolytics Biotech Inc. announced today that it has completed Phase I patient enrollment in its Phase I/II clinical trial to investigate the use of REOLYSIN(R) for patients with recurrent malignant gliomas (REO 007). The principal investigator is Dr. James Markert, Division Director of Neurosurgery, and Professor, Neurosurgery and Physiology, the University of Alabama at Birmingham.
The U.S. Food and Drug Administration today is requiring safety labeling changes for a class of antibiotics called fluoroquinolones to strengthen the warnings about the risks of mental health side effects and serious blood sugar disturbances, and make these warnings more consistent across the labeling for all fluoroquinolones taken by mouth or given by injection.
› Verified 6 days ago
Cvs Pharmacy #01784 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 17578 Dodd Blvd, Lakeville, Minnesota 55044 Phone: (952) 432-8770 | |
Cvs Pharmacy #05308 Type: Pharmacy Location: 17665 Kenwood Trl, Lakeville, Minnesota 55044 Phone: (952) 435-3784 | |
Cvs Pharmacy #16816 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 18275 Kenrick Ave, Lakeville, Minnesota 55044 Phone: (952) 892-5454 | |
Walgreens #5634 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 7560 160th St W, Lakeville, Minnesota 55044 Phone: (952) 891-1167 | |
Walgreens #7728 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 17630 Kenwood Trl, Lakeville, Minnesota 55044 Phone: (952) 892-5959 |